Profile data is unavailable for this security.
About the company
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.
- Revenue in DKK (TTM)14.36bn
- Net income in DKK3.07bn
- Incorporated2000
- Employees6.21k
- LocationNovozymes A/SKrogshoejvej 36BAGSVAERD 2880DenmarkDNK
- Phone+45 44460000
- Fax+45 44469999
- Websitehttps://www.novozymes.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clariant AG | 37.49bn | -20.59m | 46.88bn | 17.79k | -- | 2.75 | 21.08 | 1.25 | -0.009 | 0.082 | 16.57 | 7.47 | 0.6851 | 4.44 | 5.98 | 305,178.50 | 0.1505 | 3.34 | 0.2136 | 4.84 | 29.71 | 29.94 | 0.2197 | 4.35 | 0.8747 | -- | 0.4712 | 61.94 | 3.86 | 1.74 | 45.26 | 2.49 | -4.23 | 8.85 |
| Uralkaliy PAO | 20.18bn | 4.85bn | 51.94bn | 20.50k | 3.29 | 1.42 | 7.77 | 2.57 | 36.20 | 36.20 | 148.57 | 83.76 | 0.3621 | 5.06 | 8.36 | -- | 8.71 | 4.72 | 12.55 | 6.31 | 75.52 | 75.89 | 24.05 | 15.21 | 0.4072 | -- | 0.7517 | 0.00 | 7.88 | 10.40 | -117.49 | -- | 10.58 | -- |
| Johnson Matthey PLC | 93.84bn | 3.61bn | 53.56bn | 12.99k | 14.79 | 2.35 | 10.50 | 0.5708 | 2.14 | 2.14 | 55.76 | 13.49 | 1.95 | 8.69 | 7.52 | 827,302.10 | 7.49 | 8.09 | 11.10 | 11.47 | 9.46 | 8.08 | 3.84 | 3.43 | 1.00 | 12.84 | 0.3343 | 56.15 | 4.58 | -0.7465 | 38.59 | 3.95 | 7.09 | 5.26 |
| Arkema SA | 66.46bn | 3.92bn | 55.07bn | 20.00k | 14.04 | 1.40 | 6.28 | 0.8286 | 6.85 | 6.85 | 116.39 | 68.68 | 0.8649 | 5.58 | 6.64 | 444,377.80 | 5.87 | 5.12 | 7.26 | 6.35 | 21.59 | 20.84 | 6.78 | 5.61 | 1.16 | 6.97 | 0.3318 | 34.68 | 5.89 | 7.65 | 24.81 | 32.03 | 3.59 | 6.96 |
| Brenntag AG | 95.88bn | 3.61bn | 55.11bn | 17.03k | 15.21 | 2.14 | 9.85 | 0.5748 | 3.14 | 3.14 | 83.28 | 22.26 | 1.56 | 8.06 | 6.59 | 772,081.10 | 5.90 | 5.50 | 8.13 | 7.61 | 21.25 | 21.30 | 3.79 | 3.43 | 1.20 | 8.07 | 0.4271 | 40.27 | 6.87 | 5.14 | 27.74 | 6.32 | 12.68 | 6.73 |
| Chr Hansen Holding A/S | 8.67bn | 1.87bn | 68.32bn | 3.42k | 36.55 | 11.46 | 29.07 | 7.88 | 14.18 | 14.18 | 65.83 | 45.23 | 0.5925 | 3.33 | 6.57 | 2,536,475.00 | 12.76 | 12.28 | 15.56 | 14.69 | 55.98 | 54.22 | 21.54 | 20.45 | 0.87 | 21.31 | 0.5076 | 91.06 | 5.80 | 8.95 | 9.64 | 13.61 | 17.32 | 28.68 |
| Yara International ASA | 89.87bn | 3.78bn | 70.63bn | 16.76k | 18.72 | 1.23 | 7.23 | 0.786 | 18.72 | 18.72 | 445.48 | 285.61 | 0.7944 | 4.07 | 7.98 | 7,248,603.00 | 3.25 | 4.99 | 4.16 | 6.29 | 25.81 | 25.45 | 4.10 | 5.74 | 0.7485 | 7.37 | 0.3277 | 93.88 | 13.82 | -2.24 | -66.67 | -30.49 | 7.70 | -15.06 |
| Novozymes A/S | 14.36bn | 3.07bn | 74.47bn | 6.21k | 29.47 | 8.07 | 17.55 | 5.19 | 10.65 | 10.65 | 49.83 | 38.91 | 0.7335 | 2.26 | 4.95 | 2,341,706.00 | 15.68 | 16.14 | 21.39 | 20.53 | 55.70 | 57.86 | 21.38 | 21.21 | 0.7601 | 18.65 | 0.2727 | 40.24 | -0.9703 | 4.14 | 3.43 | 7.96 | 12.11 | 14.87 |
| Evonik Industries AG | 104.28bn | 4.58bn | 89.96bn | 32.57k | 19.69 | 1.43 | 7.43 | 0.8627 | 1.31 | 4.18 | 29.93 | 18.10 | 0.6547 | 4.54 | 7.93 | 387,120.90 | 2.98 | 4.49 | 3.58 | 5.48 | 28.56 | 31.10 | 4.56 | 5.91 | 1.37 | 10.55 | 0.3536 | 65.64 | 4.46 | 3.41 | 30.43 | 8.24 | -0.9601 | 2.83 |
Data as of Nov 15 2019. Currency figures normalised to Novozymes A/S's reporting currency: Danish Krone DKK
16.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 11 Nov 2019 | 7.15m | 3.01% |
| The Vanguard Group, Inc.as of 30 Sep 2019 | 5.83m | 2.46% |
| MFS International (UK) Ltd.as of 30 Sep 2019 | 4.90m | 2.07% |
| Invesco Advisers, Inc.as of 30 Sep 2019 | 4.34m | 1.83% |
| Putnam Investment Management LLCas of 28 Jun 2019 | 3.63m | 1.53% |
| Harding Loevner LPas of 30 Sep 2019 | 3.11m | 1.31% |
| Norges Bank Investment Managementas of 31 Dec 2018 | 3.10m | 1.31% |
| BlackRock Fund Advisorsas of 07 Nov 2019 | 2.63m | 1.11% |
| Walter Scott & Partners Ltd.as of 30 Sep 2019 | 2.29m | 0.97% |
| NNIP Advisors BVas of 31 Mar 2019 | 2.13m | 0.90% |
More ▼
Data from 31 Dec 2018 - 31 Oct 2019Source: FactSet Research Systems Inc.
